The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $93.72

Today's change+0.56 +0.60%
Updated September 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $93.72

Today's change+0.56 +0.60%
Updated September 27 4:00 PM EDT. Delayed by at least 15 minutes.

DexCom Inc up (U.S.)$0.56

DexCom Inc closed up Tuesday by (U.S.)$0.56 or 0.60% to (U.S.)$93.72. Over the last five days, shares have gained 1.05% and are currently 2.76% off of the 52-week high. Shares have underperformed the S&P 500 by 10.03% during the last year.

Key company metrics

  • Open(U.S.) $92.97
  • Previous close(U.S.) $93.16
  • High(U.S.) $93.90
  • Low(U.S.) $92.93
  • Bid / Ask(U.S.) $62.50 / (U.S.) $0.00
  • YTD % change+14.43%
  • Volume472,690
  • Average volume (10-day)576,719
  • Average volume (1-month)612,701
  • Average volume (3-month)854,024
  • 52-week range(U.S.) $47.92 to (U.S.) $96.38
  • Beta0.14
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.99
Updated September 27 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue137116131105
Total other revenue--------
Total revenue137116131105
Gross profit86759175
Total cost of revenue52414031
Total operating expense157135129148
Selling / general / administrative69626152
Research & development36322965
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-20-192-42
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-192-43
Income after tax-20-192-43
Income tax, total0--0--
Net income-20-192-43
Total adjustments to net income--------
Net income before extra. items-20-192-43
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-20-192-43
Inc. avail. to common incl. extra. items-20-192-43
Diluted net income-20-192-43
Dilution adjustment----0--
Diluted weighted average shares84828281
Diluted EPS excluding extraordinary itemsvalue per share-0.24-0.230.02-0.53
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.24-0.230.02-0.53